Home / Amoxicillin and Beta-Lactamase Inhibitor / Canada
CA ATC J01CR02 · updated 2 Nov 2026
Amoxicillin and Beta-Lactamase Inhibitor shortage in Canada
Is there an Amoxicillin and Beta-Lactamase Inhibitor shortage in Canada?
Yes. As of 2 Nov 2026, 3 Amoxicillin and Beta-Lactamase Inhibitor products are reported short in Canada, the first since 23 Dec 2024. The company estimate for the return is 22 Jan 2027. Main reason: manufacturing problem.
Also short in Italy, Spain, Ireland, Switzerland, Czechia, Sweden. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | JAMP AMOXI CLAV SUSPENSION (70) | JAMP PHARMA CORPORATION | 23 Dec 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP AMOXI CLAV SUSPENSION (Bottle / Bouteille 70 mL) | JAMP PHARMA CORPORATION | 12 Mar 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP AMOXI CLAV SUSPENSION (Bottle / Bouteille 100 mL) | JAMP PHARMA CORPORATION | 12 Mar 2026 | 22 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.